Association of TNF-α rs1800629 with Adult Acute B-Cell Lymphoblastic Leukemia.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
13 07 2022
Historique:
received: 21 06 2022
revised: 05 07 2022
accepted: 06 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

TNF−α influences lymphomagenesis by upregulating proinflammatory and antiapoptotic pathways. In this study, we evaluated the frequency of TNF−α rs1800629 (−308 G>A) polymorphism in newly diagnosed adult patients with acute lymphoblastic leukemia (ALL) and its correlation with age at diagnosis, gender and subtype of ALL. In this case control study, a total of 330 individuals were recruited, including 165 newly diagnosed adult patients with ALL, from the Radiation and Isotope Center in Khartoum (RICK) and 165 healthy normal controls. TNF−α rs1800629 polymorphism was tested through allele-specific polymerase chain reaction (PCR) assay. The frequency of the rs1800629 GA genotype was high (70.9% vs. 60%, OR = 1.84) in the patient group as compared to healthy controls, whereas GG and AA genotypes did not exhibit any statistically significant difference between controls and patients. Based on subtype, GG and GA rs1800629 genotypes showed increased risk of B-ALL (OR 0.46 and 2.12, respectively), whereas rs1800629 GG, GA and AA genotypes did not show any disease association with T-ALL (p > 0.05). Age at diagnosis and gender did not exhibit any association of rs1800629 with ALL in the patient group. In conclusion, rs1800629 is associated with high risk of adult B-ALL, with an insignificant effect of age at diagnosis and gender.

Identifiants

pubmed: 35886021
pii: genes13071237
doi: 10.3390/genes13071237
pmc: PMC9320751
pii:
doi:

Substances chimiques

TNF protein, human 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Immunol Rev. 2011 Nov;244(1):115-33
pubmed: 22017435
Int J Immunogenet. 2006 Feb;33(1):21-4
pubmed: 16426238
Leuk Lymphoma. 2008 Nov;49(11):2163-9
pubmed: 19021060
Br J Haematol. 1997 Apr;97(1):107-12
pubmed: 9136948
Carcinogenesis. 2007 Mar;28(3):704-12
pubmed: 17056605
In Vivo. 2016 May-Jun;30(3):265-9
pubmed: 27107085
Int J Cancer. 2007 Aug 15;121(4):819-24
pubmed: 17390373
Am J Epidemiol. 2015 Apr 15;181(8):549-62
pubmed: 25731888
Cancer Lett. 2005 Jun 1;223(1):113-9
pubmed: 15890243
Mayo Clin Proc. 2016 Nov;91(11):1645-1666
pubmed: 27814839
BMC Infect Dis. 2020 Mar 14;20(1):221
pubmed: 32171247
Tumour Biol. 2014 Dec;35(12):12509-17
pubmed: 25204673
PLoS One. 2009;4(4):e5360
pubmed: 19390683
Front Immunol. 2018 Apr 19;9:784
pubmed: 29725328
Br J Haematol. 2002 Dec;119(4):985-7
pubmed: 12472577
Leuk Res. 2012 Jun;36(6):694-8
pubmed: 22177457
Microsc Res Tech. 2000 Aug 1;50(3):216-28
pubmed: 10891887
Cold Spring Harb Perspect Biol. 2014 Dec 18;7(4):a016279
pubmed: 25524549
Semin Immunol. 2014 Jun;26(3):191-202
pubmed: 24996229
Biochim Biophys Acta. 2009 Mar;1792(3):163-72
pubmed: 19708125
Ai Zheng. 2003 Aug;22(8):861-6
pubmed: 12917036
Iran J Basic Med Sci. 2013 Sep;16(9):990-5
pubmed: 24171078
Am J Epidemiol. 2010 Apr 1;171(7):749-64
pubmed: 20228139
Lancet. 2020 Apr 4;395(10230):1146-1162
pubmed: 32247396
Tumori. 2017 Jan 21;103(1):53-59
pubmed: 27647233

Auteurs

Ezeldine K Abdalhabib (EK)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah P.O. Box 42421, Saudi Arabia.

Abdulrahman Algarni (A)

Department of Medical Laboratory Technology, College of Applied Medical Sciences, Northern Border University, Arar P.O. Box 91431, Saudi Arabia.

Muhammad Saboor (M)

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Jazan P.O. Box 45142, Saudi Arabia.
Medical Research Center, Jazan University, Jazan P.O. Box 45142, Saudi Arabia.

Fehaid Alanazi (F)

Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah P.O. Box 42421, Saudi Arabia.

Ibrahim K Ibrahim (IK)

Department of Hematology, Faculty of Medical Laboratory Sciences, Al Neelain University, Khartoum P.O. Box 12702, Sudan.

Ayman H Alfeel (AH)

Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman P.O. Box 4184, United Arab Emirates.

Abdullah M Alanazi (AM)

Gurayyat Health Affair, Regional Laboratory and Central Blood Bank, Ministry of Health, Gurayyat P.O. Box 77413, Saudi Arabia.

Abdulmajeed M Alanazi (AM)

Gurayyat Health Affair, Regional Laboratory and Central Blood Bank, Ministry of Health, Gurayyat P.O. Box 77413, Saudi Arabia.

Abdulaziz M Alruwaili (AM)

Gurayyat Health Affair, Regional Laboratory and Central Blood Bank, Ministry of Health, Gurayyat P.O. Box 77413, Saudi Arabia.

Muath H Alanazi (MH)

Gurayyat Health Affair, Regional Laboratory and Central Blood Bank, Ministry of Health, Gurayyat P.O. Box 77413, Saudi Arabia.

Nahla A Alshaikh (NA)

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Jazan P.O. Box 45142, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH